Influence of Subclinical Chronic Inflammation on the Systemic Inflammatory Response After Surgical Procedures
DOI:
https://doi.org/10.5281/zenodo.18850593Keywords:
Chronic inflammation, systemic inflammatory response, surgery, second hit, postoperative complications, perioperative riskAbstract
Subclinical chronic inflammation has emerged as a prevalent condition among individuals with metabolic, cardiovascular, and inflammatory diseases, potentially influencing the biological response to surgical trauma. Recent evidence suggests that this baseline inflammatory state acts as a modulator of the systemic inflammatory response in the perioperative period, amplifying pro-inflammatory cytokine release and increasing the risk of postoperative complications. The objective of this study was to analyze, through a narrative literature review, the role of subclinical chronic inflammation as an amplifier of the postoperative inflammatory response, in light of the “second hit” theory. A search was conducted in international databases, including clinical and experimental studies addressing baseline inflammatory markers, surgical response, and postoperative outcomes. Findings indicate that elevated preoperative levels of C-reactive protein, neutrophil-to-lymphocyte ratio, and other inflammatory cytokines are associated with greater intensity of systemic inflammatory response following surgery. Patients with obesity, metabolic syndrome, and multimorbidity demonstrate enhanced cytokine release, prolonged inflammatory activity, and higher rates of infectious complications and extended hospital stay. Mechanistically, persistent activation of innate immunity, immunometabolic dysfunction, and endothelial impairment appear to play central roles in this process. In conclusion, subclinical chronic inflammation functions as a relevant modulatory factor in perioperative risk, representing a potential biological “second hit” that amplifies the response to surgical trauma.
References
1. Costantini TW, Kornblith LZ, Pritts T, Coimbra R. The intersection of coagulation activation and inflammation after injury: what you need to know. J Trauma Acute Care Surg. 2024;96(3):347-356. doi:10.1097/TA.0000000000004190.
2. Mistry RB, Kanago AP, Panara VR. Pathological assessment of post-surgical inflammatory responses: implications for wound healing and surgical outcomes. Eur J Cardiovasc Med. 2025;15(3):878-881.
3. Hertiš Petek T, Marčun Varda N. Childhood cardiovascular health, obesity, and some related disorders: insights into chronic inflammation and oxidative stress. Int J Mol Sci. 2024;25(17):9706. doi:10.3390/ijms25179706.
4. Bayraktaroglu I, Ortí-Casañ N, Van Dam D, et al. Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease. Immun Ageing. 2025;22:33. doi:10.1186/s12979-025-00529-5.
5. Choi W, Woo GH, Kwon TH, Jeon JH. Obesity-driven metabolic disorders: the interplay of inflammation and mitochondrial dysfunction. Int J Mol Sci. 2025;26(19):9715. doi:10.3390/ijms26199715.
6. Cheng L, Cao Y, Liu S, Lv L, Zhang J, Bao J, et al. Unveiling the research advances of sepsis: pathogenesis, precise intervention and clinical perspective. Int J Surg. 2025;111(9):6260-6289. doi:10.1097/JS9.0000000000002668.
7. Gkrinia EMM, Belančić A. The mechanisms of chronic inflammation in obesity and potential therapeutic strategies: a narrative review. Curr Issues Mol Biol. 2025;47(5):357. doi:10.3390/cimb47050357.
8. Chung YE, Paik ES, Kim M, Kim NH, Lim S, Seo JH, et al. Prognostic impact of postoperative systemic immune-inflammation index changes in epithelial ovarian cancer. Cancers (Basel). 2025;17(21):3422. doi:10.3390/cancers17213422.
9. Zhou WBS, Meng J, Zhang J. Does low grade systemic inflammation have a role in chronic pain? Front Mol Neurosci. 2021;14:785214. doi:10.3389/fnmol.2021.785214.
10. Bourassa KJ, Moffitt TE, Arseneault L, Barrett-Young A, Danese A, Garrett ME, et al. PTSD and suPAR: a multicohort investigation of chronic inflammation. Brain Behav Immun. 2026;131:106159. doi:10.1016/j.bbi.2025.106159.
11. Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31-55.
12. Insua A, Galindo-Moreno P, Miron RJ, Wang HL, Monje A. Emerging factors affecting peri-implant bone metabolism. Periodontol 2000. 2023. doi:10.1111/prd.12532.
13. Shi J, Tang S, Shen C, Xu D, Tian WZ, Xu Z. The role of nutritional and inflammatory markers in predicting postoperative complications after esophagectomy for esophageal squamous cell carcinoma: mechanisms, clinical applications, and future perspectives. Front Surg. 2025;12:1671783. doi:10.3389/fsurg.2025.1671783.
14. Gigliotti S, Guerriero G, Mazza G, Garofalo E, Pavia G, Amaddeo A, et al. Perioperative blood biomarkers of infectious and non-infectious postoperative pulmonary complications: a narrative review. J Clin Med. 2026;15(2):699. doi:10.3390/jcm15020699.
15. Cavaliere G, Cimmino F, Trinchese G, Catapano A, Petrella L, D'Angelo M, et al. From obesity-induced low-grade inflammation to lipotoxicity and mitochondrial dysfunction: altered multi-crosstalk between adipose tissue and metabolically active organs. Antioxidants (Basel). 2023;12(6):1172. doi:10.3390/antiox12061172.
16. Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis C, et al. Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines. 2021;9(7):781. doi:10.3390/biomedicines9070781.
17. Butt TPL, Jazzar L, Watts P, Lehmann C. Impact of general anesthetics on postoperative infections—a narrative review. Life (Basel). 2025;15(11):1662. doi:10.3390/life15111662.
18. Wu H, Wang Y, Deng M, Zhai Z, Xue D, Luo F, et al. Preoperative inflammatory markers and tumor markers in predicting lymphatic metastasis and postoperative complications in colorectal cancer: a retrospective study. BMC Surg. 2025;25(1):71. doi:10.1186/s12893-025-02795-y.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Angelina da Costa Moreno, Fernando Barraca de Jesus Meche, João Augusto Soares, Lucca de Souza Garcia, Vitor Santos Facin

This work is licensed under a Creative Commons Attribution 4.0 International License.
Os artigos publicados na International Journal of Health and Surgical Research são licenciados sob a Creative Commons Attribution 4.0 International (CC BY 4.0).
Isso permite que outros distribuam, remixem, adaptem e criem a partir do trabalho publicado, para qualquer finalidade, incluindo comercial, desde que seja dado o devido crédito ao autor original e à revista.
Os autores mantêm os direitos autorais de seus trabalhos e concedem à revista o direito de primeira publicação.